Already sluggish health-care inflation is projected to slow down even more in 2014 as consumers, employers and the federal government continue looking to cut medical costs, a new report said Tuesday.» Read More
President Obama answers questions about privacy concerns surrounding the NSA's collection of telephone records and monitoring of Internet activity. "Congress is continually briefed" on how these activities are conducted, Obama says.
President Obama explains the "two main things Americans need to know" about the new legislation on health care. The President outlines how competition will provide an incentive to keep health care costs down, and cover millions of people who currently don't have insurance coverage.
CNBC's John Harwood provides a preview of the President's address on the benefits of the Affordable Care Act. He also addresses the NSA phone records issue.
CNBC's John Harwood presents a preview of President Obama's statement on the Affordable Care Act, and likely comments on this morning's better-than-expected jobs number, as pressure mounts for him to address NSA privacy concerns ahead of his meeting later today with China's President Xi.
Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.
A new study released Friday discovered that an average of 15 percent of flexible endoscopes used to examine GI tracts and colons at five hospitals were dirty.
DUBLIN, June 7- Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, after just 7.5 percent of the target company's shareholders accepted its previous offer.
Joseph Jimenez, CEO of Novartis, says the pharmaceutical company is investing heavily to introduce new drugs in China as the spotlight shifts from infectious to chronic disease.
Forcing hospital workers to be vaccinated for the flu as a condition of employment is not a prescription for losing employees, according to a new study.
John Noseworthy, Mayo Clinic president and CEO, discusses what his company is doing to create more jobs, the best opportunities internationally for growth and Obamacare.
Escalating costs represent one of the predictable outcomes of health reform, and many employers will turn to alternative solutions, says Keith Lemer, president of WellNet Healthcare.
Reynolds American is launching its Vuse electronic cigarettes in Colorado, with an eye toward quick national expansion. Company executives say the product will alter the landscape.
Steve Wiggins, Essex Woodlands, provides his take on companies that are best positioned to profit from ObamaCare.
Time to begin picking through the rubble, looking for stocks that have already been crushed, Cramer said.
The two-day FDA advisory committee meeting is not expected to bring about a major boost in sales for the onetime multibillion dollar product. Glaxo has said it has no plans to promote Avandia again, even if the FDA panel recommends lifting restrictions on sales of the drug, whose generic name is rosiglitazone.
Summer travelers are being bombarded with offers from travel insurance providers. Here's how to know when a policy makes sense for you.
The two-day FDA advisory committee meeting is not expected to bring about a major boost in sales for the onetime blockbuster product.
A rift between labor unions and the White House over coverage through Obamacare might be putting smiles on opponents of the health care law.
Michelle Meyer, BofA Merrill Lynch, and Richard Hoey, BNY Mellon, discuss the outlook on jobs ahead of this morning's ADP report.
Avandia's U.S. patent lapsed in 2011, a year after the FDA heavily restricted its use due to ambiguity about possible increased risk of heart attack and stroke seen in a large trial called RECORD, as well as a review of dozens of other studies.